The Company reports record Gross Margin and
positive Cash Flow and
Free Cash Flow
CALGARY,
AB, Nov. 5, 2024 /CNW/ - SNDL Inc. (NASDAQ:
SNDL) ("SNDL" or the "Company") reported its
financial and operational results for the third quarter ended
September 30, 2024. All financial
information in this press release is reported in millions of
Canadian dollars unless otherwise indicated.
SNDL has also posted a supplemental investor presentation on its
website, found at https://sndl.com.
The Company will hold a conference call and webcast
presentation at 10:00 a.m. EST
(8:00 a.m. MST) on Tuesday, November 5, 2024. The conference
call details can be found below.
THIRD QUARTER 2024 FINANCIAL AND OPERATIONAL
HIGHLIGHTS
- Net revenue for the third quarter of 2024 was $236.9 million, compared to $237.6 million in the third quarter of 2023, a
decrease of 0.3%. This decrease was driven by market softness in
the Liquor Retail segment, while both Cannabis Retail and Cannabis
Operations segments posted strong growth. This represents an
increase of 3.8% in net revenue quarter on quarter, as compared to
net revenue of $228.1 million in the
second quarter of 2024.
- Achieved a gross profit of $63.0
million, representing a record gross margin of 26.6% of
sales in the third quarter of 2024, up from 20.5% in the third
quarter of 2023. The 30% improvement in gross profit
year-over-year, or 8.3% improvement quarter-on-quarter, highlights
the continuous success of the Company's margin improvement
initiatives, including data licensing programs, mix optimization
and supply chain productivity initiatives.
- Operating loss was $18.5 million
for the third quarter of 2024, driven by a negative valuation
adjustment of equity-accounted investees (SunStream portfolio)
of $13.4 million and restructuring
charges of $1.9 million. This
compares to a loss of $16.4 million
in the third quarter of 2023, which included a favorable
equity-accounted investees valuation adjustment of $6.6 million. Excluding the volatility of these
non-cash valuation adjustments, we continue to see material
improvements in profitability.
- Cash flow was positive by $80.0
million in the third quarter of 2024, compared to
$16.5 million in the third quarter of
2023, as a result of profitability improvements and the repayment
of loan investments. Year-to-date cash flow is positive by
$67.9 million.
- Free cash flow in the third quarter of 2024 was positive
$9.2 million, compared to
$16.3 million in the third quarter of
2023. This result brings year-to-date free cash flow to negative
$2.8 million, compared to negative
$62.3 million in the first nine
months of 2023. SNDL is on pace to deliver positive free cash
flow for the 2024 calendar year, in line or ahead of guidance.
- Third quarter results reflect dynamic 8% net revenue growth
from our combined Cannabis businesses, while reaching a new record
high gross margin, despite continued softness in Liquor sales. In
addition to continued operational improvements, the following
examples highlight strategic initiatives driving SNDL towards
sustained profitable growth:
- Completed the acquisition of the principal indebtedness of
Delta 9 for a purchase price of $28.1
million in early July, becoming its senior secured creditor
with a first-priority security interest in all assets of Delta 9
and certain of its subsidiaries.
- By mid-July we announced a restructuring program aimed at
reducing corporate overheads, improving organizational efficiency,
and delivering ongoing annualized savings of over $20 million. The program is on track with more
than $2 million savings delivered in
the third quarter ($10.3 million
annualized).
- SNDL collected US$73 million in
early August from SunStream, following the loan repayment to
SunStream representing a majority of Ascend's outstanding balance
and the full outstanding balance of Jushi.
- SNDL's stalking horse bid was chosen as the successful bid in
the acquisition of the Indiva Group's business and assets, as
announced on August 29. This
acquisition has closed and positions SNDL as the market leader in
the Canadian edibles category.
- On October 21, SNDL announced the closing of the plan of
arrangement pursuant to which SNDL has privatized Nova Cannabis
Inc. through the acquisition of the remaining minority equity
interest.
- The Company had $763.8 million of
unrestricted cash, marketable securities and investments and no
outstanding debt, with $263.0 million
of unrestricted cash as of September 30,
2024. Subsequent to the end of the quarter, $37.3 million was used to pay the cash
consideration portion of the acquisition of Nova's minority equity
interest. SNDL has not raised cash through share offerings since
June 2021.
"We are pleased with the substantial progress reflected in our
results for the third quarter of 2024 as we advance towards
sustainable profitability. Our team delivered a record gross
margin, positive cash flow and free cash flow, and closed the
quarter with over a quarter billion dollars in unrestricted cash
and zero debt. We are materially improving our operational
performance while executing multiple strategic initiatives that we
believe will solidify our foundation and drive sustained,
profitable growth," said Zach
George, Chief Executive Officer of SNDL. "Our strong balance
sheet serves as a beacon for future opportunities, allowing us to
thoughtfully deploy capital into organic and inorganic investments
with attractive, risk-adjusted returns. I am more confident than
ever that our team – setting new records with each quarter – has
the expertise and drive to unlock SNDL's significant
potential."
THIRD QUARTER 2024 KEY FINANCIAL METRICS
OPERATING
SEGMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Three months ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue
|
|
144,565
|
|
|
81,144
|
|
|
25,007
|
|
|
—
|
|
|
(13,824)
|
|
|
236,892
|
|
Gross profit
|
|
36,951
|
|
|
20,710
|
|
|
5,307
|
|
|
—
|
|
|
—
|
|
|
62,968
|
|
Operating income
(loss)
|
|
11,795
|
|
|
4,395
|
|
|
(703)
|
|
|
(7,824)
|
|
|
(26,174)
|
|
|
(18,511)
|
|
Adjusted operating
income (loss) (1)
|
|
11,795
|
|
|
4,395
|
|
|
(578)
|
|
|
(7,824)
|
|
|
(24,381)
|
|
|
(16,593)
|
|
Three months ended
September 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue
|
|
151,801
|
|
|
75,539
|
|
|
20,954
|
|
|
—
|
|
|
(10,699)
|
|
|
237,595
|
|
Gross profit
|
|
37,263
|
|
|
20,046
|
|
|
(8,704)
|
|
|
—
|
|
|
—
|
|
|
48,605
|
|
Operating income
(loss)
|
|
8,278
|
|
|
3,432
|
|
|
(13,957)
|
|
|
9,886
|
|
|
(24,023)
|
|
|
(16,384)
|
|
Adjusted operating
income (loss) (1)
|
|
8,278
|
|
|
3,432
|
|
|
(14,153)
|
|
|
9,886
|
|
|
(22,992)
|
|
|
(15,549)
|
|
(1)
|
Adjusted operating
income (loss) is a specified financial measure that does not have a
standardized meaning prescribed by IFRS and therefore may not be
comparable to similar measures reported by other companies. See
"Non-IFRS Measures – Adjusted operating income (loss)"
below.
|
THIRD QUARTER 2024 RESULTS
SNDL's business is operated and reported in four segments:
Liquor Retail, Cannabis Retail, Cannabis Operations and
Investments.
Liquor Retail
SNDL is Canada's largest
private sector liquor retailer, operating 166 locations,
predominantly in Alberta, under its three retail banners:
"Wine and Beyond", "Liquor Depot", and "Ace
Liquor".
- Net revenue for Liquor Retail sales was $144.6 million in the third quarter of 2024,
compared to $151.8 million for the
same period in the year prior. The 4.8% reduction year-over-year
was driven by overall market slow-down in customer traffic.
- Same-store sales decreased by 5.0% for stores operating in the
third quarters of 2023 and 2024. Same-store sales refer to the
revenue generated by the Company's existing retail liquor
locations, which operated during the current and comparative
periods.
- Gross profit for Liquor Retail was $37.0
million, or 25.6% of sales, in the third quarter of 2024,
compared to $37.3 million, or 24.5%
of sales, in the third quarter of 2023. The Company achieved record
gross margin for its Liquor Retail segment in August of 2024, with
margins reaching 26.5%, mainly driven by productivity in
procurement, mix management and pricing optimization
initiatives.
- Operating income for Liquor Retail was $11.8 million in the third quarter of 2024,
compared to $8.3 million in the third
quarter of 2023, an impressive 42.5% improvement despite lower
revenue.
- SNDL's proprietary data licensing program for Liquor Retail
which launched in the first quarter of 2024, saw a 23% increase in
revenue compared to the prior quarter.
As of November 4, 2024, the Ace
Liquor store count was 134, the Liquor Depot store count was 19,
and the Wine and Beyond store count was 13.
Cannabis Retail
SNDL is Canada's largest
private-sector cannabis retailer by number of stores, operating 187
locations under its three retail banners: "Value Buds",
"Spiritleaf", and "Superette". The Company's Cannabis
Retail strategy is based on several pillars, including the quality
of its store locations, its range of products, and the unique
experiences provided to customers. Using data and insights from a
large volume of monthly transactions enables SNDL to leverage
technology and analytics to inform and improve its retail
strategy.
- Net revenue for Cannabis Retail in the third quarter of 2024
was $81.1 million, compared to
$75.5 million in the third quarter of
2023. The 7.4% increase year-over-year was driven by productivity
improvements and new stores opened throughout the year.
- Same-store sales increased 2.3% for stores operating in the
third quarters of 2023 and 2024, in line with the first half of the
year. Same-store sales refer to the revenue generated by the
Company's existing retail cannabis locations, which operated during
the current and comparative periods.
- Gross profit for Cannabis Retail was $20.7 million, or 25.5% of sales, in the third
quarter of 2024, compared to $20.0
million, or 26.5% of sales, in the third quarter of 2023, a
3.3% increase year-over-year.
- Operating income for Cannabis Retail was $4.4 million in the third quarter of 2024,
compared to $3.4 million in the third
quarter of 2023, an increase of 28.1% year-over-year.
- SNDL's proprietary data licensing program generated revenue of
$4.0 million for the third quarter of
2024, in line with the same period in the year prior.
As of November 4, 2024, the
Spiritleaf store count was 81 (20 corporate stores and 61 franchise
stores), the Superette store count was 4 corporate stores, and the
Value Buds store count was 102 corporate stores.
Cannabis Operations
SNDL has a diverse brand portfolio from value to premium,
emphasizing premium inhalable formats and a full suite of 2.0
products. With enhanced procurement capabilities and plans to
continue evolving toward a cost-effective cultivation and
manufacturing operation, the Cannabis Operations segment is a key
enabler of SNDL's vertical integration strategy.
- Net revenue for Cannabis Operations for the third quarter of
2024 was $25.0 million, up 19.3% from
$21.0 million in the third quarter of
2023, mainly as a result of increasing provincial board and
Business-to-Business distribution and a continued focus on consumer
innovation, quality and operational efficiencies.
- We are encouraged by the strong demand for our products, as
evidenced by the opening of 71 new distribution points during the
third quarter and the increase in international orders for the
fourth quarter.
- Gross profit for the segment in the third quarter of 2024 of
$5.3 million, an increase of
$14.0 million from negative
$8.7 million in the third quarter of
2023. The record gross margin of 21.2% for the segment is supported
by a strong productivity program.
- Operating income for the third quarter of 2024 improved by
$13.3 million over the same period in
the prior year, going from negative $14.0
million to negative $0.7
million. The substantial increase in operating income
results from margin expansion, reduced overhead spending, and
operational efficiencies.
Investments
- As of September 30, 2024, the
Company has deployed capital to a portfolio of cannabis-related
investments with a carrying value of $500.4
million, including $451.1
million to SunStream Bancorp Inc. ("SunStream").
This carrying value was reduced by $100.1
million during the third quarter of 2024, mainly driven by
the cash collections on outstanding loan balances to SunStream from
Ascend Wellness Holdings, Inc. ("Ascend") and Jushi Holdings
Inc. ("Jushi").
- In July 2024, Ascend repaid
approximately 80% of their outstanding loan balance
with SunStream, amounting to US$12
million. On July 31, 2024,
Jushi repaid their full outstanding balance of US$53 million with SunStream. Both repayments
occurred several months ahead of the maturity date, increasing
SNDL's cash liquidity and enabling the deployment of additional
capital to support our growth agenda.
- In the third quarter of 2024, the investment portfolio
generated negative operating income of $7.8
million, including a $13.4
million negative valuation adjustment of
equity-accounted investees (SunStream portfolio). This
compares to a positive operating income of $9.9 million in the third quarter of 2023, which
included a favorable $6.6 million
valuation adjustment of equity-accounted investees.
- SunStream is a joint venture sponsored by SNDL. During 2023,
SunStream directed the formation of the SunStream USA group of companies ("SunStream
USA Group") in connection with
the restructuring of certain loans provided by SunStream. SunStream
USA Group is anticipated to be a
U.S. platform with one or more independent third-party investors,
which will be independently managed and governed.
- During the third quarter of 2024, the credit portfolio
controlled by SunStream comprised five investments: Jushi,
SKYMINT Brands ("Skymint"), Ascend, Surterra Holdings, Inc.
d/b/a Parallel ("Parallel"), and Columbia Care Inc.
- The previously announced transactions to acquire certain
operations and assets of Parallel and Skymint continue to be
subject to certain conditions and regulatory approvals.
- SNDL continues to monitor local and international regulatory
changes, including the potential reclassification of marijuana from
a Schedule I drug to Schedule III drug under the U.S. Controlled
Substances Act, or the outcome of amendment 3 vote to legalize
recreational marijuana for adults aged 21 and older in Florida. These decisions do not directly
affect SNDL's operations, which are located solely in Canada, though they would have a favorable
effect on the SunStream joint venture investments in the United States.
Equity Position
- $763.8 million of unrestricted
cash, marketable securities and investments, including investments
in equity-accounted investees, and no outstanding debt at
September 30, 2024, resulting in a
net book value of $1.2 billion.
- Subsequent to the three months ended September 30, 2024, SNDL issued 159,792
shares as the share consideration for the acquisition of Nova's
minority equity interest, in addition to the $37.7 million in cash consideration mentioned
above.
- On November 13, 2023, the Company
announced that its board of directors had approved a renewal of the
share repurchase program upon its expiry on November 20, 2023. The Company's share repurchase
program continues to be available to lower the outstanding share
float. SNDL will continue to assess opportunities to utilize
the program to the extent that management believes it is in the
best interest of SNDL's shareholders. Subsequent to the quarter
end, in October 2024 the Company
repurchased 59,417 common shares for cancellation under the share
repurchase program at a price of US$1.90 per share.
This press release is intended to be read in conjunction with
the Company's condensed consolidated interim financial statements
and the notes thereto for the three and nine months ended
September 30, 2024, and the
accompanying Management's Discussion and Analysis. These documents
are available under the Company's profile on SEDAR+ at
www.sedarplus.ca and EDGAR at www.sec.gov/edgar.shtml.
CONFERENCE CALL
The Company will hold a conference call and webcast
presentation at 10:00 a.m. EST
(8:00 a.m. MST) on Tuesday, November 5, 2024.
WEBCAST ACCESS
To access the live webcast of the call,
please visit the following link:
https://edge.media-server.com/mmc/p/fjuij37h
REPLAY
A replay of the webcast will be available at
https://sndl.com/financials/quarterly-results/default.aspx
ABOUT SNDL INC.
SNDL is a public company whose shares are traded on the Nasdaq
under the symbol "SNDL." SNDL is the largest private-sector
liquor and cannabis retailer in Canada with retail banners that include Ace
Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf,
Superette and Firesale. SNDL is a licensed cannabis producer and
one of the largest vertically integrated cannabis companies in
Canada specializing in low-cost
biomass sourcing, indoor cultivation, product innovation, low-cost
manufacturing facilities, and a cannabis brand portfolio that
includes Top Leaf, Contraband, Citizen Stash, Sundial Cannabis,
Palmetto, Spiritleaf Selects Bon Jak, Versus, Value Buds, Namaste,
Re-up, Grasslands and Vacay. SNDL's investment portfolio seeks to
deploy strategic capital through direct and indirect investments
and partnerships throughout the North American cannabis
industry. For more information on SNDL, please go
to https://sndl.com/.
Forward-Looking Information Cautionary
Statement
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"), including,
but not limited to, statements regarding the Company's operational
goals, the Company's margin improvement initiatives, the Company's
ability to achieve long-term, sustainable profitability, growth and
efficiencies, the Company's long-term strategic plan, expectations
with respect to the restructuring project, the benefits of the
Company's Investment Segment portfolio, expectations with respect
to sharing information with investors, the Company's approach to
its Wine and Beyond banner, the Company's retail strategy,
expectations with respect to the Company's Cannabis Operations
segment, the Company's vertical integration strategy, expectations
with respect to the Company's pursuit of EU-GMP certification,
expectations with respect to the ability of the Company's to expand
its international export footprint, the Company's proprietary data
licensing program, expansion of product offerings (including the
expected expansion of the Company's private labels), performance of
the Company's investments, including through the SunStream joint
venture and SunStream USA Group,
expectations with respect to the SunStream USA Group, the timing and closing of the
transactions with Parallel and Skymint, potential local and
international regulatory changes, the share repurchase program,
including the anticipated benefits thereof, and any other potential
forms of shareholder value creation. Forward-looking statements are
frequently characterized by words such as "aim", "anticipate",
"assume", "believe", "contemplate", "continue", "could", "due",
"estimate", "expect", "goal", "intend", "may", "objective", "plan",
"predict", "potential", "positioned", "pioneer", "seek", "should",
"target", "will", "would", and other similar expressions that are
predictions of or indicate future events and future trends, or the
negative of these terms or other comparable terminology. These
forward-looking statements are based on current expectations,
estimates, forecasts and projections about the Company's business
and the industry in which it operates and management's beliefs and
assumptions and are not guarantees of future performance or
development and involve known and unknown risks, uncertainties and
other factors that are in some cases beyond its
control. Forward-looking statements are based on the opinions
and estimates of management at the date the statements are made
and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
Please see "Risk Factors" in the Company's Annual Information Form
dated March 20, 2024, and the risk
factors included in our other public disclosure documents for a
discussion of the material risk factors that could cause actual
results to differ materially from the forward-looking information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable
law.
Condensed Consolidated Interim Statement of Loss and
Comprehensive Loss
(Unaudited – expressed in thousands of
Canadian dollars, except per share amounts)
|
|
Three months
ended
September 30
|
|
|
|
2024
|
|
|
2023
|
|
Net
revenue
|
|
|
236,892
|
|
|
|
237,595
|
|
Cost of
sales
|
|
|
173,924
|
|
|
|
188,990
|
|
Gross
profit
|
|
|
62,968
|
|
|
|
48,605
|
|
|
|
|
|
|
|
|
|
|
Investment
income
|
|
|
5,577
|
|
|
|
3,416
|
|
Share of profit (loss)
of equity-accounted investees
|
|
|
(13,401)
|
|
|
|
6,581
|
|
|
|
|
|
|
|
|
|
|
General and
administrative
|
|
|
49,980
|
|
|
|
48,235
|
|
Sales and
marketing
|
|
|
2,813
|
|
|
|
3,271
|
|
Research and
development
|
|
|
76
|
|
|
|
57
|
|
Depreciation and
amortization
|
|
|
13,389
|
|
|
|
15,545
|
|
Share-based
compensation
|
|
|
5,702
|
|
|
|
5,373
|
|
Restructuring
(recovery) costs
|
|
|
1,918
|
|
|
|
708
|
|
Asset
impairment
|
|
|
(258)
|
|
|
|
1,783
|
|
Loss on disposition of
assets
|
|
|
35
|
|
|
|
14
|
|
Operating income
(loss)
|
|
|
(18,511)
|
|
|
|
(16,384)
|
|
|
|
|
|
|
|
|
|
|
Other income
(expenses)
|
|
|
609
|
|
|
|
(5,443)
|
|
Loss before income
tax
|
|
|
(17,902)
|
|
|
|
(21,827)
|
|
Income tax recovery
(expense)
|
|
|
(1,434)
|
|
|
|
—
|
|
Net loss from
continuing operations
|
|
|
(19,336)
|
|
|
|
(21,827)
|
|
Net loss from
discontinued operations
|
|
|
—
|
|
|
|
—
|
|
Net
loss
|
|
|
(19,336)
|
|
|
|
(21,827)
|
|
|
|
|
|
|
|
|
|
|
Equity-accounted
investees - share of other comprehensive income (loss)
|
|
|
(4,802)
|
|
|
|
11,124
|
|
Comprehensive income
(loss)
|
|
|
(24,138)
|
|
|
|
(10,703)
|
|
|
|
|
|
|
|
|
|
|
Net loss from
continuing operations attributable to:
|
|
|
|
|
|
|
|
|
Owners of the
Company
|
|
|
(19,328)
|
|
|
|
(21,784)
|
|
Non-controlling
interest
|
|
|
(8)
|
|
|
|
(43)
|
|
|
|
|
(19,336)
|
|
|
|
(21,827)
|
|
Net loss
attributable to:
|
|
|
|
|
|
|
|
|
Owners of the
Company
|
|
|
(19,328)
|
|
|
|
(21,784)
|
|
Non-controlling
interest
|
|
|
(8)
|
|
|
|
(43)
|
|
|
|
|
(19,336)
|
|
|
|
(21,827)
|
|
Comprehensive income
(loss) attributable to:
|
|
|
|
|
|
|
|
|
Owners of the
Company
|
|
|
(24,130)
|
|
|
|
(10,660)
|
|
Non-controlling
interest
|
|
|
(8)
|
|
|
|
(43)
|
|
|
|
|
(24,138)
|
|
|
|
(10,703)
|
|
Condensed Consolidated Interim Statement of Financial
Position
(Unaudited – expressed in thousands of Canadian
dollars)
As at
|
|
September 30,
2024
|
|
December 31,
2023
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
Cash and cash
equivalents
|
|
|
262,976
|
|
|
195,041
|
|
Restricted
cash
|
|
|
20,215
|
|
|
19,891
|
|
Marketable
securities
|
|
|
483
|
|
|
225
|
|
Accounts
receivable
|
|
|
24,589
|
|
|
27,059
|
|
Biological
assets
|
|
|
901
|
|
|
429
|
|
Inventory
|
|
|
127,863
|
|
|
129,060
|
|
Prepaid expenses and
deposits
|
|
|
15,507
|
|
|
22,464
|
|
Investments
|
|
|
22,900
|
|
|
3,400
|
|
Assets held for
sale
|
|
|
19,051
|
|
|
6,375
|
|
Net investment in
subleases
|
|
|
2,927
|
|
|
2,970
|
|
|
|
|
497,412
|
|
|
406,914
|
|
Non-current
assets
|
|
|
|
|
|
Long-term deposits and
receivables
|
|
|
3,702
|
|
|
4,837
|
|
Right of use
assets
|
|
|
118,409
|
|
|
129,679
|
|
Property, plant and
equipment
|
|
|
128,310
|
|
|
152,916
|
|
Net investment in
subleases
|
|
|
16,820
|
|
|
18,396
|
|
Intangible
assets
|
|
|
77,019
|
|
|
73,149
|
|
Investments
|
|
|
26,413
|
|
|
29,660
|
|
Equity-accounted
investees
|
|
|
451,068
|
|
|
538,331
|
|
Goodwill
|
|
|
123,924
|
|
|
119,282
|
|
Total
assets
|
|
|
1,443,077
|
|
|
1,473,164
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
Accounts payable and
accrued liabilities
|
|
|
54,038
|
|
|
68,210
|
|
Lease
liabilities
|
|
|
34,541
|
|
|
30,537
|
|
Derivative
warrants
|
|
|
52
|
|
|
4,400
|
|
|
|
|
88,631
|
|
|
103,147
|
|
Non-current
liabilities
|
|
|
|
|
|
Lease
liabilities
|
|
|
122,959
|
|
|
136,492
|
|
Other
liabilities
|
|
|
7,214
|
|
|
4,185
|
|
Total
liabilities
|
|
|
218,804
|
|
|
243,824
|
|
|
|
|
|
|
|
Shareholders'
equity
|
|
|
|
|
|
Share
capital
|
|
|
2,383,233
|
|
|
2,375,950
|
|
Warrants
|
|
|
667
|
|
|
2,260
|
|
Contributed
surplus
|
|
|
81,591
|
|
|
73,014
|
|
Contingent
consideration
|
|
|
2,279
|
|
|
2,279
|
|
Accumulated
deficit
|
|
|
(1,288,505)
|
|
|
(1,260,851)
|
|
Accumulated other
comprehensive income
|
|
|
28,949
|
|
|
19,417
|
|
Total shareholders'
equity
|
|
|
1,208,214
|
|
|
1,212,069
|
|
Non-controlling
interest
|
|
|
16,059
|
|
|
17,271
|
|
Total liabilities
and shareholders' equity
|
|
|
1,443,077
|
|
|
1,473,164
|
|
Condensed Consolidated Interim Statement of Cash
Flows
(Unaudited – expressed in thousands of Canadian
dollars)
|
|
|
|
Three months
ended
September 30
|
|
|
|
|
|
|
2024
|
|
|
2023
|
|
|
Cash provided by
(used in):
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
|
|
|
|
Net loss for the
period
|
|
|
|
|
(19,336)
|
|
|
|
(21,827)
|
|
|
Adjustments
for:
|
|
|
|
|
|
|
|
|
|
Income tax
expense
|
|
|
|
|
1,434
|
|
|
|
—
|
|
|
Interest and fee
income
|
|
|
|
|
(5,577)
|
|
|
|
(3,445)
|
|
|
Change in fair value
of biological assets
|
|
|
|
|
167
|
|
|
|
1,819
|
|
|
Share-based
compensation
|
|
|
|
|
5,702
|
|
|
|
5,373
|
|
|
Depreciation and
amortization
|
|
|
|
|
13,970
|
|
|
|
16,602
|
|
|
Loss on disposition of
assets
|
|
|
|
|
35
|
|
|
|
14
|
|
|
Inventory impairment
and obsolescence
|
|
|
|
|
413
|
|
|
|
9,126
|
|
|
Finance costs,
net
|
|
|
|
|
1,740
|
|
|
|
2,142
|
|
|
Change in estimate of
fair value of derivative warrants
|
|
|
|
|
(3,848)
|
|
|
|
2,840
|
|
|
Unrealized foreign
exchange loss
|
|
|
|
|
80
|
|
|
|
68
|
|
|
Asset impairment
(reversal)
|
|
|
|
|
(258)
|
|
|
|
1,783
|
|
|
Share of (profit) loss
of equity-accounted investees
|
|
|
|
|
13,401
|
|
|
|
(6,581)
|
|
|
Realized loss on
settlement of marketable securities
|
|
|
|
|
—
|
|
|
|
46,082
|
|
|
Unrealized (gain) loss
on marketable securities
|
|
|
|
|
—
|
|
|
|
(46,053)
|
|
|
Additions to
marketable securities
|
|
|
|
|
(327)
|
|
|
|
—
|
|
|
Proceeds from
settlement of marketable securities
|
|
|
|
|
—
|
|
|
|
3,241
|
|
|
Income distributions
from equity-accounted investees
|
|
|
|
|
10,715
|
|
|
|
—
|
|
|
Interest
received
|
|
|
|
|
4,496
|
|
|
|
3,325
|
|
|
Change in non-cash
working capital
|
|
|
|
|
(13)
|
|
|
|
13,033
|
|
|
Net cash provided by
operating activities from continuing operations
|
|
|
|
|
22,794
|
|
|
|
27,542
|
|
|
Net cash provided by
operating activities from discontinued operations
|
|
|
|
|
—
|
|
|
|
—
|
|
|
Net cash provided by
operating activities
|
|
|
|
|
22,794
|
|
|
|
27,542
|
|
|
Investing
activities
|
|
|
|
|
|
|
|
|
|
Additions to property,
plant and equipment
|
|
|
|
|
(1,706)
|
|
|
|
(3,042)
|
|
|
Additions to
intangible assets
|
|
|
|
|
(2,421)
|
|
|
|
(32)
|
|
|
Changes to
investments
|
|
|
|
|
(18,952)
|
|
|
|
195
|
|
|
Capital distributions
from equity-accounted investees
|
|
|
|
|
89,758
|
|
|
|
—
|
|
|
Proceeds from disposal
of property, plant and equipment
|
|
|
|
|
—
|
|
|
|
1,150
|
|
|
Change in non-cash
working capital
|
|
|
|
|
(191)
|
|
|
|
730
|
|
|
Net cash provided by
(used in) investing activities
|
|
|
|
|
66,488
|
|
|
|
(999)
|
|
|
Financing
activities
|
|
|
|
|
|
|
|
|
|
Change in restricted
cash
|
|
|
|
|
(243)
|
|
|
|
(205)
|
|
|
Payments on lease
liabilities, net
|
|
|
|
|
(9,780)
|
|
|
|
(9,793)
|
|
|
Change in non-cash
working capital
|
|
|
|
|
783
|
|
|
|
(17)
|
|
|
Net cash used in
financing activities
|
|
|
|
|
(9,240)
|
|
|
|
(10,015)
|
|
|
Change in cash and cash
equivalents
|
|
|
|
|
80,042
|
|
|
|
16,528
|
|
|
Cash and cash
equivalents, beginning of period
|
|
|
|
|
182,934
|
|
|
|
185,455
|
|
|
Cash and cash
equivalents, end of period
|
|
|
|
|
262,976
|
|
|
|
201,983
|
|
|
NON-IFRS MEASURES
Certain specified financial measures in this news release are
non-IFRS measures. These terms are not defined by IFRS and,
therefore, may not be comparable to similar measures reported by
other companies. These non-IFRS financial measures should not be
considered in isolation or as an alternative for or superior to
measures of performance prepared in accordance with IFRS. These
measures are presented and described in order to provide
shareholders and potential investors with additional measures in
understanding the Company's operating results in the same manner as
the management team.
ADJUSTED OPERATING INCOME (LOSS)
Adjusted operating
income (loss) is a non-IFRS financial measure which the Company
uses to evaluate its operating performance. Adjusted operating
income (loss) provides information to investors, analysts, and
others to aid in understanding and evaluating the Company's
operating results in a similar manner to its management team. The
Company defines adjusted operating income (loss) as operating
income (loss) less restructuring costs (recovery), goodwill and
intangible asset impairments and asset impairments triggered by
restructuring activities.
The following tables reconcile adjusted to un-adjusted operating
income (loss) for the periods noted.
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Three months ended
September 30, 2024
|
|
Operating income
(loss)
|
|
11,795
|
|
|
4,395
|
|
|
(703)
|
|
|
(7,824)
|
|
|
(26,174)
|
|
|
(18,511)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring
costs
|
|
—
|
|
|
—
|
|
|
125
|
|
|
—
|
|
|
1,793
|
|
|
1,918
|
|
Adjusted operating
income (loss)
|
|
11,795
|
|
|
4,395
|
|
|
(578)
|
|
|
(7,824)
|
|
|
(24,381)
|
|
|
(16,593)
|
|
($000s)
|
Liquor
Retail
|
|
Cannabis
Retail
|
|
Cannabis
Operations
|
|
Investments
|
|
Corporate
|
|
Total
|
|
Three months ended
September 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss)
|
|
8,278
|
|
|
3,432
|
|
|
(13,957)
|
|
|
9,886
|
|
|
(24,023)
|
|
|
(16,384)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring costs
(recovery)
|
|
—
|
|
|
—
|
|
|
(323)
|
|
|
—
|
|
|
1,031
|
|
|
708
|
|
Intangible asset
impairments
|
|
—
|
|
|
—
|
|
|
127
|
|
|
—
|
|
|
—
|
|
|
127
|
|
Adjusted operating
income (loss)
|
|
8,278
|
|
|
3,432
|
|
|
(14,153)
|
|
|
9,886
|
|
|
(22,992)
|
|
|
(15,549)
|
|
FREE CASH FLOW
Free cash flow is a non-IFRS financial measure which the Company
uses to evaluate its financial performance. Free cash flow provides
information which management believes to be useful to investors,
analysts and others in understanding and evaluating the Company's
ability to generate positive cash flows as it removes cash used for
non-operational items. The Company defines free cash flow as the
total change in cash and cash equivalents less cash used for common
share repurchases, dividends (if any), changes to debt instruments,
changes to long-term investments, net cash used for acquisitions
plus cash provided by dispositions (if any).
The following table reconciles free cash flow to change in cash
and cash equivalents for the periods noted.
|
|
Three months
ended
September 30
|
|
|
Nine months
ended
September 30
|
|
($000s)
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Change in cash and cash
equivalents (Cash Flow)
|
|
|
80,042
|
|
|
|
16,528
|
|
|
|
67,935
|
|
|
|
(77,603)
|
|
Adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of common
shares
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,536
|
|
Changes to long-term
investments
|
|
|
(70,806)
|
|
|
|
(195)
|
|
|
|
(72,342)
|
|
|
|
17,496
|
|
Acquisitions, net of
cash acquired
|
|
|
—
|
|
|
|
—
|
|
|
|
1,654
|
|
|
|
(3,695)
|
|
Free cash
flow
|
|
|
9,236
|
|
|
|
16,333
|
|
|
|
(2,753)
|
|
|
|
(62,266)
|
|
SOURCE SNDL Inc.